Helaina is a New York-based biotechnology company using precision fermentation to produce human-equivalent bioactive proteins. Its first commercial product, effera, is a human-identical lactoferrin made in yeast that matches the amino acid sequence of the protein found in mother's milk. Founded in 2019 by food scientist Laura Katz, Helaina sells effera as a B2B ingredient to consumer wellness and supplement brands, targeting women's health, gut health, active nutrition and healthy aging. The company has raised roughly $84 million in equity funding, including a $45 million Series B in 2024.
NuCicer is a Davis, California agtech and food-tech company breeding a new generation of high-protein chickpeas. Spun out of UC Davis and built on the largest pool of chickpea genetic diversity on earth, the company uses predictive (precision) breeding and genomics to develop chickpea varieties with up to 75% more protein than conventional beans - alongside better flavor, lower fat, and higher fiber. NuCicer sells whole beans, functional flours, protein powders, and bespoke trait packages to food brands seeking minimally processed, sustainable plant-protein ingredients that out-compete soy and pea isolates on taste and texture.